Most GEP signatures consider T cell inflamed microenvironments characterized by the upregulation of IFN-γ signaling, antigen presentation, and immune checkpoint-related genes when predicting response to ICIs across multiple cancer types. The gene discussed is IFNG; the disease is cancer.